News GenoScreen Corporate

The skin microbiota plays a vital role in maintaining the skin's integrity and functionality. It contributes to the proper regulation of organisms and organs, allowing the skin to perform its essential functions, including acting as a barrier. See our latest article "Why preservce the skin microbiota ?"

The European objective for 2050 is to achieve a healthy and more resilient soil. To support this objective, on Friday 7th of July, the European Commission published a Proposal for a Directive on Soil Monitoring and Resilience (Soil Monitoring Law) [1].

As a training organization, GenoScreen is offering bioinformatics training courses for professionals in 2024. Whether you are a novice or an expert, our training courses will give you the skills you need to master the analysis of NGS data and gain autonomy.

Although considered an extinct calamity, leprosy is an infectious disease still present in more than hundred countries.

The skin serves as the first line of interaction with the external environment and as a defence mechanism against the physical, chemical, or biological stresses and challenges it encounters. The skin microbiota plays a key role in these interactions and defence functions. Formerly known as "skin flora", it colonises every square centimetre of the skin. Its role is fundamental to both skin health and the overall well-being of the body. What are the factors that influence its composition, and what disrupts its functions?

A targeted deep sequencing assay identifies multidrugresistant tuberculosis strains responsible for silent outbreaks

The cutaneous microbiota has become a subject of interest for the nutri-cosmetics, dermo-cosmetics and beauty industries. New products have been launched that claim to respect the skin's microbiota, as well as skincare products containing a new category of active ingredients - pre-, pro- and post-biotics - designed to protect, rebalance or maintain its equilibrium. These innovations have been made possible by significant scientific and technological advances in the study of microbiota.

For over a decade, GenoScreen has been committed to the fight against tuberculosis (TB), one of the deadliest infectious diseases in the world. The company's journey began with the groundbreaking development of MIRU-VNTR typing kits in 2013 which marked a turning point in TB research and control by enabling rapid and accurate identification of TB strains. This breakthrough technology provided an unparalleled level of resolution in characterizing TB strains, essential for the management and control of TB outbreaks, allowing researchers and public health authorities to track the spread of the disease more efficiently and prevent further outbreaks.

By continuing your visit to this site, you accept the use of statistics cookies
More information I accept Decline